Shorepoint Capital Partners »

Novo Nordisk A/S shares owned by Shorepoint Capital Partners

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Shorepoint Capital Partners from 13F filings

Historical chart of Shorepoint Capital Partners investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Shorepoint Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Shorepoint Capital Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $7.5M 82k 90.94
2023-06-30 $7.6M 47k 161.83
2023-03-31 $7.3M 46k 159.14
2022-12-31 $5.9M 44k 135.34

More positions owned by Shorepoint Capital Partners

Ishares Tr 0-3 Mnth Treasry (Principal) (SGOV)
Broadcom (Principal) (AVGO)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
AutoZone (AZO)
Chevron Corporation (CVX)
Travelers Companies (TRV)
Novo-nordisk A S Adr (NVO)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Mastercard Incorporated Cl A (MA)
Thermo Fisher Scientific (TMO)
Agnico (Principal) (AEM)
Abbvie (ABBV)
Apple (AAPL)

View all positions for Shorepoint Capital Partners

Top funds holding Novo Nordisk A/S

Jennison Associates
Fisher Investments
Bank of America Corporation
Fayez Sarofim & Co
Folketrygdfondet
Polen Capital Management
T. Rowe Price Associates
Everett Harris & Co
State Farm Mutual Automobile Insurance Company
Goldman Sachs Group
Jpmorgan Chase & Co
WCM Investment Management
Sustainable Growth Advisers
Wells Fargo & Company
Royal Bank of Canada

View all funds holding Novo Nordisk A/S